[1]Day CP.Non-alcoholic fatty liver disease:current concepts and management strategies[J].ClinMed, 2006, 6 (1) :19-25.
|
[2]Targher G, Arcaro G.Non-alcoholic fatty liver disease and in-creased risk of cardiovascular disease[J].Atherosclerosis, 2007, 191 (2) :235-240.
|
[3] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) :164-166.
|
[4]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) :161-163.
|
[5]范建高, 李锋, 蔡晓波, 等.1995至2002年上海宝钢职工队列人群脂肪肝患病率变化[J].肝脏, 2006, (11) 3:154-157.
|
[6]范建高.非酒精性脂肪肝的临床流行病研究[J].中华消化杂志, 2002, 22 (2) :106-107.
|
[7]马金霞, 张建富, 李嘉陵, 等.平均红细胞体积和红细胞体积分布宽度临床意义的分析[J].南京医科大学学报, 2001;21 (2) :13.
|
[8]张桂芹, 关盼香.脂肪肝患者血脂与PLT和红细胞粒度分布的相关性分析[J].中国现代药物应用杂志, 2009, 3 (10) :62.
|
[9]谭力学, 李孝生, 刘增权.非酒精性脂肪肝患者红细胞容积分布密度变化的观察及其临床意义[J].陕西医学杂志, 2003, 32 (12) :1072-1073.
|
[10] 董蕴.红细胞变形能力下降的机理研究[J].中风与神经疾病杂志, 1993, 10 (3) :145.
|
[11]胡学琴.红细胞的检测在非酒精性脂肪肝早期诊断中的重要价值[J].实用医技杂志, 2004, 11 (17) :1716.
|
[12]Takashimizu S, Shiraishi K, Watanabe N, et al.Scanning electron microscopic studies on morphological abnormalities of erythrocytes in alcoholic liver diseases[J].Alcohol Clin Exp Res, 2000, 24 (Suppl4) :S81-S86.
|
[13]王泰龄, 江正辉.酒精性肝病[M].北京:中国医药出版社, 2001:57—60.
|
[14]Kazemi-Shirazi L, Veloso MP, Frommlet F, et al.Differentiation of nonalcoholic from alcoholic steatohepatitis:are routine laboratory markers useful[J].Wien Klin Wochenschr, 2008, 120 (1-2) :25-30.
|
[15]Maruyama S, Hirayama C, Yamamoto S, et al.Red blood cell sta-tus in alcoholic and non-alcoholic liver disease[J].J Lab Clin Med, 2001, 138 (5) :332-337.
|
[16]Shella S.Diseases of The Liver And Biliary Syste[M].Eleventh E-dition.London:Blackwell Publishing, 2002:90.
|
[17]kaneda H, Hashimoto E, Yatsuji S, et al.Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease[J].Gastroenterol Hepa-tol, 2006, 21 (9) :1459-1465.
|
[18]陈彤君.脂肪肝患者平均血小板体积和血清脂质变化的临床研究[J].北京医学, 2005, (27) 8:484.
|
[19]Craig W S.Increased platelet volume sign of in paired thrombopoi-esis in diabetes mellitus[J].K1in Wochenschr, 1995, 37:157-158.
|
[20]Park KS, Lee YS, Park HW, et al.Factors associated or related to with pathological severity of nonalcoholic fatty liver disease[J].Ko-rean J Intern Med, 2004, 19 (1) :19-26.
|
[2] | Huang YaoBin, Li HuanMin, Li ChunGuang. Association of cholecystectomy with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2014, 30(7): 644-646. doi: 10.3969/j.issn.1001-5256.2014.07.017 |
[3] | Dong Shu, Liu Ping, Sun MingYu. Role of “two-hit” in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2012, 28(7): 551-555. |
[4] | Niu ChunYan, Yan Rong, Tian Yu, Ma HuiXia, Jiao ShuJiang. The prevalence of fatty liver disease and its relationship with metabolic syndrome[J]. Journal of Clinical Hepatology, 2010, 26(2): 167-169. |
[5] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[6] | Xu LaMei, Sun DanLi, Zhang YuShu, Zhang ZhenYu, Yuan Jie, Du TongXin. The clinical significance of adiponectin expression and its diagnostic value combined with liver function tests and liver/spleen CT value in Non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2010, 26(2): 170-172. |
[7] | Zhang JinHua, Long Hui, Liu Qun, Wang GuiFang. Analysis of risk factors of type 2 diabetes in patients with Nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2009, 25(2): 129-130. |
[8] | Huang MiaoZhen. Effect of Salvia injection on lipid mechanism and tumor necrosis factor α in the nonalcohic fatty liver of rats fed a high-fat diet[J]. Journal of Clinical Hepatology, 2008, 24(5): 355-358. |
[9] | Zhan GuoQing, Li ShengJun, Zhou Hong, Zhu Lin, Hu Bo, Xie XingRong. A clinical observation on the efficacy of tiopionin combined with Vitamin E for alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(6): 440-442. |
[10] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[11] | Xing LingXiang, He YongWen. Experiment study on nonalcoholic fatty liver model induced by injection of oxytetracycline intraperitoneally in rats[J]. Journal of Clinical Hepatology, 2007, 23(1): 29-31. |
[12] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[13] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[14] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[15] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[20] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |